|
1
|
Huang M, Li Y, Zhang H and Nan F: Breast
cancer stromal fibroblasts promote the generation of CD44
CD24− cells through SDF-1/CXCR4 interaction. J Exp Clin
Cancer Res. 29:802010. View Article : Google Scholar
|
|
2
|
Guerrero-Preston R, Hadar T, Ostrow KL,
Soudry E, Echenique M, Ili-Gangas C, Pérez G, Perez J,
Brebi-Mieville P, Deschamps J, et al: Differential promoter
methylation of kinesin family member 1a in plasma is associated
with breast cancer and DNA repair capacity. Oncol Rep. 32:505–512.
2014.PubMed/NCBI
|
|
3
|
Pang H, Lu H, Song H, Meng Q, Zhao Y, Liu
N, Lan F, Liu Y, Yan S, Dong X, et al: Prognostic values of
osteopontin-c, E-cadherin and β-catenin in breast cancer. Cancer
Epidemiol. 37:985–992. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu L, Salnikov AV, Bauer N,
Aleksandrowicz E, Labsch S, Nwaeburu C, Mattern J, Gladkich J,
Schemmer P, Werner J, et al: Triptolide reverses hypoxia-induced
epithelial-mesenchymal transition and stem-like features in
pancreatic cancer by NF-kappaB downregulation. Int J Cancer.
134:2489–2503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jethwa P, Naqvi M, Hardy RG, Hotchin NA,
Roberts S, Spychal R and Tselepis C: Overexpression of Slug is
associated with malignant progression of esophageal adenocarcinoma.
World J Gastroenterol. 14:1044–1052. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sánchez-Martín L, Sánchez-Mateos P and
Cabañas C: CXCR7 impact on CXCL12 biology and disease. Trends Mol
Med. 19:12–22. 2013. View Article : Google Scholar
|
|
9
|
Luker KE and Luker GD: Functions of CXCL12
and CXCR4 in breast cancer. Cancer Lett. 238:30–41. 2006.
View Article : Google Scholar
|
|
10
|
Ray P, Lewin SA, Mihalko LA, Lesher-Perez
SC, Takayama S, Luker KE and Luker GD: Secreted CXCL12 (SDF-1)
forms dimers under physiological conditions. Biochem J.
442:433–442. 2012. View Article : Google Scholar
|
|
11
|
Papatheodorou H, Papanastasiou AD,
Sirinian C, Scopa C, Kalofonos HP, Leotsinidis M and Papadaki H:
Expression patterns of SDF1/CXCR4 in human invasive breast
carcinoma and adjacent normal stroma: Correlation with tumor
clinicopathological parameters and patient survival. Pathol Res
Pract. 210:662–667. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hinton CV, Avraham S and Avraham HK: Role
of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to
the brain. Clin Exp Metastasis. 27:97–105. 2010. View Article : Google Scholar
|
|
13
|
Sun Y, Mao X, Fan C, Liu C, Guo A, Guan S,
Jin Q, Li B, Yao F and Jin F: CXCL12-CXCR4 axis promotes the
natural selection of breast cancer cell metastasis. Tumour Biol.
35:7765–7773. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nagasawa T, Kikutani H and Kishimoto T:
Molecular cloning and structure of a pre-B-cell growth-stimulating
factor. Proc Natl Acad Sci USA. 91:2305–2309. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Müller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Phillips RJ, Burdick MD, Lutz M, Belperio
JA, Keane MP and Strieter RM: The stromal derived
factor-1/CXCL12-CXC chemokine receptor 4 biological axis in
non-small cell lung cancer metastases. Am J Respir Crit Care Med.
167:1676–1686. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Williams SA, Harata-Lee Y, Comerford I,
Anderson RL, Smyth MJ and McColl SR: Multiple functions of CXCL12
in a syngeneic model of breast cancer. Mol Cancer. 9:2502010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hattermann K, Holzenburg E, Hans F, Lucius
R, Held-Feindt J and Mentlein R: Effects of the chemokine CXCL12
and combined internalization of its receptors CXCR4 and CXCR7 in
human MCF-7 breast cancer cells. Cell Tissue Res. 357:253–266.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao Z, Wang X, Wu K, Zhao Y and Hu G:
Pancreatic stellate cells increase the invasion of human pancreatic
cancer cells through the stromal cell-derived factor-1/CXCR4 axis.
Pancreatology. 10:186–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang YP, Wu XH, Xing HY and Du XY: Effect
of chemokine CXCL12 and its receptor CXCR4 on proliferation,
migration and invasion of epithelial ovarian cancer cells. Zhonghua
Fu Chan Ke Za Zhi. 42:403–407. 2007.(In Chinese). PubMed/NCBI
|
|
21
|
Kang H, Watkins G, Parr C, Douglas-Jones
A, Mansel RE and Jiang WG: Stromal cell derived factor-1: Its
influence on invasiveness and migration of breast cancer cells in
vitro, and its association with prognosis and survival in human
breast cancer. Breast Cancer Res. 7:R402–R410. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang R, Lv Q, Meng W, Tan Q, Zhang S, Mo X
and Yang X: Comparison of mammosphere formation from breast cancer
cell lines and primary breast tumors. J Thorac Dis. 6:829–837.
2014.PubMed/NCBI
|
|
23
|
Bae SN, Arand G, Azzam H, Pavasant P,
Torri J, Frandsen TL and Thompson EW: Molecular and cellular
analysis of basement membrane invasion by human breast cancer cells
in Matrigel-based in vitro assays. Breast Cancer Res Treat.
24:241–255. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luker KE, Lewin SA, Mihalko LA, Schmidt
BT, Winkler JS, Coggins NL, Thomas DG and Luker GD: Scavenging of
CXCL12 by CXCR7 promotes tumor growth and metastasis of
CXCR4-positive breast cancer cells. Oncogene. 31:4750–4758. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Boimel PJ, Smirnova T, Zhou ZN, Wyckoff J,
Park H, Coniglio SJ, Qian BZ, Stanley ER, Cox D, Pollard JW, et al:
Contribution of CXCL12 secretion to invasion of breast cancer
cells. Breast Cancer Res. 14:R232012. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Goswami S, Sahai E, Wyckoff JB, Cammer M,
Cox D, Pixley FJ, Stanley ER, Segall JE and Condeelis JS:
Macrophages promote the invasion of breast carcinoma cells via a
colony-stimulating factor-1/epidermal growth factor paracrine loop.
Cancer Res. 65:5278–5283. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Porcile C, Bajetto A, Barbieri F, Barbero
S, Bonavia R, Biglieri M, Pirani P, Florio T and Schettini G:
Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates
ovarian cancer cell growth through the EGF receptor
transactivation. Exp Cell Res. 308:241–253. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Porta C, Subhra Kumar B, Larghi P, Rubino
L, Mancino A and Sica A: Tumor promotion by tumor-associated
macrophages. Adv Exp Med Biol. 604:67–86. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kucia M, Ratajczak J and Ratajczak MZ:
Bone marrow as a source of circulating CXCR4+
tissue-committed stem cells. Biol Cell. 97:133–146. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mukherjee D and Zhao J: The role of
chemokine receptor CXCR4 in breast cancer metastasis. Am J Cancer
Res. 3:46–57. 2013.PubMed/NCBI
|
|
31
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar
|
|
32
|
Ogony JW, Malahias E, Vadigepalli R and
Anni H: Ethanol alters the balance of Sox2, Oct4, and Nanog
expression in distinct subpopulations during differentiation of
embryonic stem cells. Stem Cells Dev. 22:2196–2210. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brahimi-Horn MC, Chiche J and Pouysségur
J: Hypoxia and cancer. J Mol Med Berl. 85:1301–1307. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Heddleston JM, Li Z, McLendon RE,
Hjelmeland AB and Rich JN: The hypoxic microenvironment maintains
glioblastoma stem cells and promotes reprogramming towards a cancer
stem cell phenotype. Cell Cycle. 8:3274–3284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bolós V, Peinado H, Pérez-Moreno MA, Fraga
MF, Esteller M and Cano A: The transcription factor Slug represses
E-cadherin expression and induces epithelial to mesenchymal
transitions: A comparison with Snail and E47 repressors. J Cell
Sci. 116:499–511. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maier HJ, Schmidt-Strassburger U, Huber
MA, Wiedemann EM, Beug H and Wirth T: NF-kappaB promotes
epithelial-mesenchymal transition, migration and invasion of
pancreatic carcinoma cells. Cancer Lett. 295:214–228. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chua HL, Bhat-Nakshatri P, Clare SE,
Morimiya A, Badve S and Nakshatri H: NF-kappaB represses E-cadherin
expression and enhances epithelial to mesenchymal transition of
mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2.
Oncogene. 26:711–724. 2007. View Article : Google Scholar
|
|
39
|
Min C, Eddy SF, Sherr DH and Sonenshein
GE: NF-kappaB and epithelial to mesenchymal transition of cancer. J
Cell Biochem. 104:733–744. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shin SR, Sánchez-Velar N, Sherr DH and
Sonenshein GE: 7,12-dimethylbenz(a)anthracene treatment of a c-rel
mouse mammary tumor cell line induces epithelial to mesenchymal
transition via activation of nuclear factor-kappaB. Cancer Res.
66:2570–2575. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huber MA, Beug H and Wirth T:
Epithelial-mesenchymal transition: NF-kappaB takes center stage.
Cell Cycle. 3:1477–1480. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jiang R, Li Y, Xu Y, Zhou Y, Pang Y, Shen
L, Zhao Y, Zhang J, Zhou J, Wang X, et al: EMT and CSC-like
properties mediated by the IKKβ/IκBα/RelA signal pathway via the
transcriptional regulator, Snail, are involved in the
arsenite-induced neoplastic transformation of human keratinocytes.
Arch Toxicol. 87:991–1000. 2013. View Article : Google Scholar
|
|
43
|
Yi T, Zhai B, Yu Y, Kiyotsugu Y, Raschle
T, Etzkorn M, Seo HC, Nagiec M, Luna RE, Reinherz EL, et al:
Quantitative phosphoproteomic analysis reveals system-wide
signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem
cells. Proc Natl Acad Sci USA. 111:E2182–E2190. 2014. View Article : Google Scholar : PubMed/NCBI
|
